Filing Details
- Accession Number:
- 0000899243-21-002117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-14 20:44:58
- Reporting Period:
- 2021-01-12
- Accepted Time:
- 2021-01-14 20:44:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1812364 | Relay Therapeutics Inc. | RLAY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1180428 | J Mark Levin | 29 Newbury Street, 3Rd Floor Boston MA 02116 | No | No | Yes | No | |
1192595 | I Robert Tepper | 29 Newbury Street, 3Rd Floor Boston MA 02116 | No | No | Yes | No | |
1192603 | P Kevin Starr | 29 Newbury Street, 3Rd Floor Boston MA 02116 | No | No | Yes | No | |
1569705 | Third Rock Ventures Iii, L.p. | C/O Third Rock Ventures, Llc 29 Newbury Street, 3Rd Floor Boston MA 02116 | No | No | Yes | No | |
1637299 | Trv Gp Iii, Llc | 29 Newbury Street, 3Rd Floor Boston MA 02116 | No | No | Yes | No | |
1637300 | Third Rock Ventures Gp Iii, L.p. | 29 Newbury Street, 3Rd Floor Boston MA 02116 | No | No | Yes | No | |
1688325 | Trv Gp Iv, Llc | 29 Newbury Street, 3Rd Floor Boston MA 02116 | No | No | Yes | No | |
1688326 | Third Rock Ventures Gp Iv, L.p. | 29 Newbury Street, 3Rd Floor Boston MA 02116 | No | No | Yes | No | |
1688327 | Third Rock Ventures Iv, L.p. | C/O Third Rock Ventures, Llc 29 Newbury Street, 3Rd Floor Boston MA 02116 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-01-12 | 1,500,000 | $40.00 | 9,051,115 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-13 | 1,247,873 | $40.01 | 7,803,242 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-13 | 8,727 | $41.08 | 7,794,515 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-13 | 42,860 | $42.12 | 7,751,655 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-13 | 4,325 | $44.00 | 7,747,330 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-13 | 7,412 | $44.73 | 7,739,918 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-13 | 805,050 | $40.01 | 2,006,147 | No | 4 | S | Indirect | See Footnotes |
Common Stock | Disposition | 2021-01-13 | 5,630 | $41.08 | 2,000,517 | No | 4 | S | Indirect | See Footnotes |
Common Stock | Disposition | 2021-01-13 | 27,650 | $42.12 | 1,972,867 | No | 4 | S | Indirect | See Footnotes |
Common Stock | Disposition | 2021-01-13 | 2,791 | $44.00 | 1,970,076 | No | 4 | S | Indirect | See Footnotes |
Common Stock | Disposition | 2021-01-13 | 4,782 | $44.73 | 1,965,294 | No | 4 | S | Indirect | See Footnotes |
Common Stock | Disposition | 2021-01-14 | 1,965,294 | $41.00 | 0 | No | 4 | S | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | See Footnotes |
No | 4 | S | Indirect | See Footnotes |
No | 4 | S | Indirect | See Footnotes |
No | 4 | S | Indirect | See Footnotes |
No | 4 | S | Indirect | See Footnotes |
No | 4 | S | Indirect | See Footnotes |
Footnotes
- These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.04 to $44.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (8).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (9).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.04 to $44.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (10).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (11).
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (12).
- These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- Each of the reporting persons disclaims the existence of a Section 13(d) "group" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.